Related references
Note: Only part of the references are listed.The evolutionary history of 2,658 cancers
Moritz Gerstung et al.
NATURE (2020)
Longitudinal immunosequencing in healthy people reveals persistent T cell receptors rich in highly public receptors
Nathaniel D. Chu et al.
BMC IMMUNOLOGY (2019)
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials
Sandra P. D'Angelo et al.
LANCET ONCOLOGY (2018)
Pervasive intra-tumour heterogeneity and subclonal selection across cancer types
Stefan Dentro et al.
CANCER RESEARCH (2018)
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Xiaotu Ma et al.
NATURE (2018)
Detection and benchmarking of somatic mutations in cancer genomes using RNA-seq data
Alexandre Coudray et al.
PEERJ (2018)
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2017)
Telomeres in cancer: tumour suppression and genome instability
John Maciejowski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli et al.
SCIENCE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma
Sam Behjati et al.
NATURE COMMUNICATIONS (2017)
Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
Pornpimol Charoentong et al.
CELL REPORTS (2017)
Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: a multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)
J. Martin-Broto et al.
ANNALS OF ONCOLOGY (2017)
TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells
Taiwen Li et al.
CANCER RESEARCH (2017)
Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses
Melissa Amber Burgess et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Different Facets of Copy Number Changes: Permanent, Transient, and Adaptive
Sweta Mishra et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik-Zainal et al.
NATURE (2016)
CTLPScanner: a web server for chromothripsis-like pattern detection
Jian Yang et al.
NUCLEIC ACIDS RESEARCH (2016)
MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data
Yu Fan et al.
GENOME BIOLOGY (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial
Giovanni Grignani et al.
LANCET ONCOLOGY (2015)
Inconsistency and features of single nucleotide variants detected in whole exome sequencing versus transcriptome sequencing: A case study in lung cancer
Timothy D. O'Brien et al.
METHODS (2015)
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors
Rachel Litman Flynn et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
F. Favero et al.
ANNALS OF ONCOLOGY (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
The genetic basis for inactivation of Wnt pathway in human osteosarcoma
Xiaoling Du et al.
BMC CANCER (2014)
Estimating telomere length from whole genome sequence data
Zhihao Ding et al.
NUCLEIC ACIDS RESEARCH (2014)
Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma
Jennifer A. Perry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution
Sally M. Dewhurst et al.
CANCER DISCOVERY (2014)
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
Xiang Chen et al.
CELL REPORTS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome?
Arkarachai Fungtammasan et al.
GENOME RESEARCH (2012)
Absolute quantification of somatic DNA alterations in human cancer
Scott L. Carter et al.
NATURE BIOTECHNOLOGY (2012)
Alternative lengthening of telomeres pathway: Recombination-mediated telomere maintenance mechanism in human cells
Akira Nabetani et al.
JOURNAL OF BIOCHEMISTRY (2011)
Aneuploidy Drives Genomic Instability in Yeast
Jason M. Sheltzer et al.
SCIENCE (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads
Kai Ye et al.
BIOINFORMATICS (2009)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11
Claus Lundegaard et al.
NUCLEIC ACIDS RESEARCH (2008)
Immune cells as mediators of solid tumor metastasis
David G. DeNardo et al.
CANCER AND METASTASIS REVIEWS (2008)
Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma
Yu-Jen Chen et al.
CANCER RESEARCH (2006)
Open source clustering software
MJL de Hoon et al.
BIOINFORMATICS (2004)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Application of equality constraints on variables during alternating least squares procedures
MH Van Benthem et al.
JOURNAL OF CHEMOMETRICS (2002)
Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
SS Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
